Travel-associated disease among US residents visiting US GeoSentinel clinics after return from international travel
- PMID: 25261506
- PMCID: PMC4624308
- DOI: 10.1093/fampra/cmu063
Travel-associated disease among US residents visiting US GeoSentinel clinics after return from international travel
Abstract
Background: US residents make 60 million international trips annually. Family practice providers need to be aware of travel-associated diseases affecting this growing mobile population.
Objective: To describe demographics, travel characteristics and clinical diagnoses of US residents who present ill after international travel.
Methods: Descriptive analysis of travel-associated morbidity and mortality among US travellers seeking care at 1 of the 22 US practices and clinics participating in the GeoSentinel Global Surveillance Network from January 2000 to December 2012.
Results: Of the 9624 ill US travellers included in the analysis, 3656 (38%) were tourist travellers, 2379 (25%) missionary/volunteer/research/aid workers (MVRA), 1580 (16%) travellers visiting friends and relatives (VFRs), 1394 (15%) business travellers and 593 (6%) student travellers. Median (interquartile range) travel duration was 20 days (10-60 days). Pre-travel advice was sought by 45%. Hospitalization was required by 7%. Compared with other groups of travellers, ill MVRA travellers returned from longer trips (median duration 61 days), while VFR travellers disproportionately required higher rates of inpatient care (24%) and less frequently had received pre-travel medical advice (20%). Illnesses of the gastrointestinal tract were the most common (58%), followed by systemic febrile illnesses (18%) and dermatologic disorders (17%). Three deaths were reported. Diagnoses varied according to the purpose of travel and region of exposure.
Conclusions: Returning ill US international travellers present with a broad spectrum of travel-associated diseases. Destination and reason for travel may help primary health care providers to generate an accurate differential diagnosis for the most common disorders and for those that may be life-threatening.
Keywords: Diagnosis; epidemiology; morbidity; prevention; surveillance; travel..
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest: Dr. Connor reported receiving royalties from Elsevier for ‘Travel Medicine, 3rd Edition’. Dr. Marano reported that she is an employee of GlaxoSmithKline Vaccines and that she is a GlaxoSmithKline stock option owner. No other author reported conflict of interest.
Figures


References
-
- US Department of Commerce, ITA, Office of Travel and Tourism Industries. [accessed August 12, 2014];United States Resident Travel Abroad. 2010 Released July 2012. http://tinet.ita.doc.gov.
-
- LaRocque RC, Rao SR, Lee J, Ansdell V, et al. Global TravEpiNet Consortium. Global TravEpiNet: a national consortium of clinics providing care to international travelers–analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009–2011. Clin Infect Dis. 2012;54:455–62. - PubMed
-
- Hill DR, Ericsson CD, Pearson RD, et al. Infectious Diseases Society of America. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1499–539. - PubMed
-
- Newman RD, Parise ME, Barber AM, Steketee RW. Malaria-related deaths among U.S. travelers, 1963–2001. Ann Intern Med. 2004;141:547–55. - PubMed
-
- Morens DM, Fauci AS. Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA. 2008;299:214–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical